selected publications
-
Journal Article
- Pilot study of the safety and effect of adalimumab on pain, physical function, and musculoskeletal disease in mucopolysaccharidosis types I and II 2017
- A longitudinal study of emotional adjustment, quality of life and adaptive function in attenuated MPS II 2016
- Association of somatic burden of disease with age and neuropsychological measures in attenuated mucopolysaccharidosis types I, II and VI 2016
- Elevated TNF-alpha is associated with pain and physical disability in mucopolysaccharidosis types I, II, and VI. Molecular Genetics and Metabolism. 2016
- Mucopolysaccharidosis (MPS) physical symptom score: development, reliability, and validity 2016
- Biomarkers of bone remodeling in children with mucopolysaccharidosis types I, II, and VI. Journal of Pediatric Rehabilitation Medicine. 2014
-
Abstract
- TNF-a levels are increased in children with mucopolysaccharidosis types I, II, and VI treated with ERT [abstract]. Molecular Genetics and Metabolism. 2014
- The MPS health assessment questionnaire: preliminary normative and validity data [abstract]. Molecular Genetics and Metabolism. 2014